Inventor
SHERER BRIAN A
US19 patents
⚠️ This page may combine multiple inventors who share the name “SHERER BRIAN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK PATENT GMBH
17 patentsUS10947213B1Mar 16, 2021
TLR7/8 antagonists and uses thereof
MERCK PATENT GMBH4 citations83
US10399957B2Sep 3, 2019
TLR7/8 antagonists and uses thereof
MERCK PATENT GMBH4 citations83
US9676757B2Jun 13, 2017
Heterocyclic compounds as NaV channel inhibitors and uses thereof
MERCK PATENT GMBH12 citations83
US10836750B1Nov 17, 2020
TLR7/8 antagonists and uses thereof
MERCK PATENT GMBH2 citations73
US10793553B2Oct 6, 2020
TLR7/8 antagonists and uses thereof
MERCK PATENT GMBH2 citations73
US11629134B2Apr 18, 2023
TLR7/8 antagonists and uses thereof
MERCK PATENT GMBH2 citations72
US10696649B2Jun 30, 2020
TLR7/8 antagonists and uses thereof
MERCK PATENT GMBH3 citations72
US10544122B2Jan 28, 2020
TLR7/8 antagonists and uses thereof
MERCK PATENT GMBH2 citations72
US9771370B2Sep 26, 2017
Compounds for the inhibition of indoleamine-2,3-dioxygenase
MERCK PATENT GMBH3 citations72
US10253023B2Apr 9, 2019
Heteroaryl compounds as BTK inhibitors and uses thereof
MERCK PATENT GMBH3 citations71
US10947214B2Mar 16, 2021
TLR7/8 antagonists and uses thereof
MERCK PATENT GMBH2 citations69
US10428080B2Oct 1, 2019
TBK/IKK inhibitor compounds and uses thereof
MERCK PATENT GMBH1 citations62
US11098041B2Aug 24, 2021
Heteroaryl compounds as BTK inhibitors and uses thereof
MERCK PATENT GMBH1 citations61
US11512069B2Nov 29, 2022
TLR7/8 antagonists and uses thereof
MERCK PATENT GMBH0 citations59
US10377745B2Aug 13, 2019
Heterocyclic compounds as NaV channel inhibitors and uses thereof
MERCK PATENT GMBH0 citations51
US10329297B2Jun 25, 2019
Compounds for the inhibition of indoleamine-2,3-dioxygenase
MERCK PATENT GMBH0 citations51
US9988391B2Jun 5, 2018
TBK/IKK inhibitor compounds and uses thereof
MERCK PATENT GMBH1 citations51